Tourmaline Bio OverviewTourmaline Bio EBIT
EBIT (Earnings Before Interest and Taxes) analysis for TRML.
Quarterly EBIT
-$25.97M
↓ 18.22% YoY
As of Jun 30, 2025
Annual EBIT (TTM)
-$102.49M
↓ 87.95% YoY
Trailing 12 months ending Jun 30, 2025
Tourmaline Bio OverviewEBIT (Earnings Before Interest and Taxes) analysis for TRML.
As of Jun 30, 2025
Trailing 12 months ending Jun 30, 2025